Pediatrix Medical Group, Inc. Financials
This page shows Pediatrix Medical Group, Inc. (MD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Pediatrix Medical Group, Inc. has an operating margin of -3.4%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 0.4% the prior year.
Pediatrix Medical Group, Inc.'s revenue grew a modest 0.9% year-over-year to $2.0B. This slow but positive growth earns a score of 31/100.
Pediatrix Medical Group, Inc. carries a low D/E ratio of 0.80, meaning only $0.80 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 82/100, indicating a strong balance sheet with room for future borrowing.
Pediatrix Medical Group, Inc.'s current ratio of 1.47 indicates adequate short-term liquidity, earning a score of 39/100. The company can meet its near-term obligations, though with limited headroom.
Pediatrix Medical Group, Inc. passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Pediatrix Medical Group, Inc. generates $-2.09 in operating cash flow ($206.6M OCF vs -$99.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Pediatrix Medical Group, Inc. earns $-1.7 in operating income for every $1 of interest expense (-$68.7M vs $40.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Pediatrix Medical Group, Inc. generated $2.0B in revenue in fiscal year 2024. This represents an increase of 0.9% from the prior year.
Pediatrix Medical Group, Inc.'s EBITDA was -$36.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 183.9% from the prior year.
Pediatrix Medical Group, Inc. reported -$99.1M in net income in fiscal year 2024. This represents a decrease of 64.0% from the prior year.
Pediatrix Medical Group, Inc. earned $-1.19 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 63.0% from the prior year.
Pediatrix Medical Group, Inc. held $229.9M in cash against $611.2M in long-term debt as of fiscal year 2024.
Pediatrix Medical Group, Inc. had 86M shares outstanding in fiscal year 2024. This represents an increase of 2.2% from the prior year.
Pediatrix Medical Group, Inc.'s operating margin was -3.4% in fiscal year 2024, reflecting core business profitability. This is down 3.8 percentage points from the prior year.
Pediatrix Medical Group, Inc.'s net profit margin was -4.9% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.9 percentage points from the prior year.
Pediatrix Medical Group, Inc. spent $1.7M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 85.3% from the prior year.
MD Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $492.9M+5.1% | $468.8M+2.3% | $458.4M-8.8% | $502.4M-0.4% | $504.3M+1.9% | $495.1M-0.3% | $496.4M-2.0% | $506.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $60.8M+9.1% | $55.7M-4.9% | $58.6M-7.8% | $63.6M+12.4% | $56.6M-6.0% | $60.2M+13.4% | $53.1M-7.6% | $57.4M |
| Operating Income | $68.1M+13.7% | $59.9M+86.5% | $32.1M-18.3% | $39.3M+124.9% | -$157.7M-1092.5% | $15.9M+114.3% | -$111.5M-376.8% | $40.3M |
| Interest Expense | $8.9M-2.1% | $9.1M-0.3% | $9.2M-5.7% | $9.7M-5.8% | $10.3M-2.7% | $10.6M+5.1% | $10.1M-2.8% | $10.4M |
| Income Tax | $16.1M+2.3% | $15.7M+113.6% | $7.4M+158.2% | $2.8M+119.4% | -$14.7M-488.0% | $3.8M+126.0% | -$14.6M-254.3% | $9.4M |
| Net Income | $71.7M+82.6% | $39.3M+89.3% | $20.7M-32.0% | $30.5M+119.9% | -$153.0M-3892.4% | $4.0M+103.2% | -$124.3M-681.0% | $21.4M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MD Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B+4.6% | $2.1B+5.4% | $2.0B-7.4% | $2.2B+7.9% | $2.0B-8.0% | $2.2B-2.3% | $2.2B-4.6% | $2.3B |
| Current Assets | $717.2M+17.0% | $613.0M+24.7% | $491.7M-23.1% | $639.6M+49.0% | $429.2M+0.6% | $426.5M-11.8% | $483.5M+15.0% | $420.5M |
| Cash & Equivalents | $340.1M+51.3% | $224.7M+127.1% | $99.0M-57.0% | $229.9M+1085.1% | $19.4M+142.6% | $8.0M-89.1% | $73.3M+245.9% | $21.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $231.1M-3.3% | $239.0M-1.5% | $242.5M-6.7% | $260.0M-5.2% | $274.2M-3.4% | $283.7M+4.2% | $272.3M-1.8% | $277.4M |
| Goodwill | $1.3B+1.0% | $1.2B0.0% | $1.2B0.0% | $1.2B+0.3% | $1.2B-11.1% | $1.4B+0.7% | $1.4B-9.7% | $1.5B |
| Total Liabilities | $1.3B+3.2% | $1.3B+5.3% | $1.2B-13.2% | $1.4B+7.7% | $1.3B-1.8% | $1.3B-4.3% | $1.4B+0.9% | $1.4B |
| Current Liabilities | $392.5M+15.1% | $341.0M+25.8% | $271.1M-37.6% | $434.1M+40.0% | $310.2M+25.4% | $247.3M-36.4% | $388.9M+11.0% | $350.4M |
| Long-Term Debt | $577.2M-1.1% | $583.9M-1.1% | $590.5M-3.4% | $611.2M | N/A | N/A | $622.2M+0.1% | $621.7M |
| Total Equity | $890.7M+6.8% | $833.8M+5.6% | $789.2M+3.2% | $764.9M+8.3% | $706.5M-17.5% | $856.2M+0.8% | $849.1M-12.3% | $968.0M |
| Retained Earnings | -$116.8M+38.0% | -$188.5M+17.2% | -$227.8M+8.3% | -$248.5M+16.7% | -$298.5M-105.2% | -$145.4M+2.7% | -$149.5M-493.5% | -$25.2M |
MD Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $137.3M+0.1% | $137.2M+216.8% | -$117.5M-188.3% | $133.0M+24.4% | $107.0M+185.4% | -$125.2M-280.8% | $69.3M-13.4% | $79.9M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $6.6M+192.3% | -$7.2M+4.2% | -$7.5M-285.1% | -$1.9M+85.0% | -$12.9M+20.6% | -$16.2M-30.7% | -$12.4M+11.3% | -$14.0M |
| Financing Cash Flow | -$28.6M-570.6% | -$4.3M+29.4% | -$6.0M-21.6% | -$5.0M+94.0% | -$82.7M-208.5% | $76.2M+1705.3% | -$4.7M+90.6% | -$50.6M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $20.9M+9884.2% | $209K-86.7% | $1.6M+144.0% | $643K+5745.5% | $11K-98.8% | $887K | $0-100.0% | $133K |
MD Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 13.8%+1.0pp | 12.8%+5.8pp | 7.0%-0.8pp | 7.8%+39.1pp | -31.3%-34.5pp | 3.2%+25.7pp | -22.5%-30.4pp | 8.0% |
| Net Margin | 14.5%+6.2pp | 8.4%+3.9pp | 4.5%-1.6pp | 6.1%+36.4pp | -30.3%-31.1pp | 0.8%+25.9pp | -25.0%-29.3pp | 4.2% |
| Return on Equity | 8.1%+3.3pp | 4.7%+2.1pp | 2.6%-1.4pp | 4.0% | N/A | 0.5% | N/A | 2.2% |
| Return on Assets | 3.3%+1.4pp | 1.9%+0.8pp | 1.0%-0.4pp | 1.4%+9.1pp | -7.7%-7.9pp | 0.2%+5.8pp | -5.6%-6.5pp | 0.9% |
| Current Ratio | 1.83+0.0 | 1.80-0.0 | 1.81+0.3 | 1.47+0.1 | 1.38-0.3 | 1.72+0.5 | 1.24+0.0 | 1.20 |
| Debt-to-Equity | 0.65-0.1 | 0.70-0.0 | 0.75-0.1 | 0.80-1.0 | 1.82+0.3 | 1.53+0.8 | 0.73+0.1 | 0.64 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Pediatrix Medical Group, Inc.'s annual revenue?
Pediatrix Medical Group, Inc. (MD) reported $2.0B in total revenue for fiscal year 2024. This represents a 0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Pediatrix Medical Group, Inc.'s revenue growing?
Pediatrix Medical Group, Inc. (MD) revenue grew by 0.9% year-over-year, from $2.0B to $2.0B in fiscal year 2024.
Is Pediatrix Medical Group, Inc. profitable?
No, Pediatrix Medical Group, Inc. (MD) reported a net income of -$99.1M in fiscal year 2024, with a net profit margin of -4.9%.
What is Pediatrix Medical Group, Inc.'s earnings per share (EPS)?
Pediatrix Medical Group, Inc. (MD) reported diluted earnings per share of $-1.19 for fiscal year 2024. This represents a -63.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Pediatrix Medical Group, Inc.'s EBITDA?
Pediatrix Medical Group, Inc. (MD) had EBITDA of -$36.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Pediatrix Medical Group, Inc. have?
As of fiscal year 2024, Pediatrix Medical Group, Inc. (MD) had $229.9M in cash and equivalents against $611.2M in long-term debt.
What is Pediatrix Medical Group, Inc.'s operating margin?
Pediatrix Medical Group, Inc. (MD) had an operating margin of -3.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Pediatrix Medical Group, Inc.'s net profit margin?
Pediatrix Medical Group, Inc. (MD) had a net profit margin of -4.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Pediatrix Medical Group, Inc.'s operating cash flow?
Pediatrix Medical Group, Inc. (MD) generated $206.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Pediatrix Medical Group, Inc.'s total assets?
Pediatrix Medical Group, Inc. (MD) had $2.2B in total assets as of fiscal year 2024, including both current and long-term assets.
Does Pediatrix Medical Group, Inc. buy back shares?
Yes, Pediatrix Medical Group, Inc. (MD) spent $1.7M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Pediatrix Medical Group, Inc. have outstanding?
Pediatrix Medical Group, Inc. (MD) had 86M shares outstanding as of fiscal year 2024.
What is Pediatrix Medical Group, Inc.'s current ratio?
Pediatrix Medical Group, Inc. (MD) had a current ratio of 1.47 as of fiscal year 2024, which is considered adequate.
What is Pediatrix Medical Group, Inc.'s debt-to-equity ratio?
Pediatrix Medical Group, Inc. (MD) had a debt-to-equity ratio of 0.80 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Pediatrix Medical Group, Inc.'s return on assets (ROA)?
Pediatrix Medical Group, Inc. (MD) had a return on assets of -4.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Pediatrix Medical Group, Inc.'s Piotroski F-Score?
Pediatrix Medical Group, Inc. (MD) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Pediatrix Medical Group, Inc.'s earnings high quality?
Pediatrix Medical Group, Inc. (MD) has an earnings quality ratio of -2.09x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Pediatrix Medical Group, Inc. cover its interest payments?
Pediatrix Medical Group, Inc. (MD) has an interest coverage ratio of -1.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Pediatrix Medical Group, Inc.?
Pediatrix Medical Group, Inc. (MD) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.